197 related articles for article (PubMed ID: 34527806)
1. Dendrimer-Triamcinolone Acetonide Reduces Neuroinflammation, Pathological Angiogenesis, and Neuroretinal Dysfunction in Ischemic Retinopathy.
Cho H; Kambhampati SP; Lai MJ; Zhou L; Lee G; Xie Y; Hui Q; Kannan RM; Duh EJ
Adv Ther (Weinh); 2021 Feb; 4(2):. PubMed ID: 34527806
[TBL] [Abstract][Full Text] [Related]
2. Intracellular delivery of dendrimer triamcinolone acetonide conjugates into microglial and human retinal pigment epithelial cells.
Kambhampati SP; Mishra MK; Mastorakos P; Oh Y; Lutty GA; Kannan RM
Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):239-49. PubMed ID: 25701805
[TBL] [Abstract][Full Text] [Related]
3. Endogenous erythropoietin protects neuroretinal function in ischemic retinopathy.
Mowat FM; Gonzalez F; Luhmann UF; Lange CA; Duran Y; Smith AJ; Maxwell PH; Ali RR; Bainbridge JW
Am J Pathol; 2012 Apr; 180(4):1726-39. PubMed ID: 22342523
[TBL] [Abstract][Full Text] [Related]
4. Polyamidoamine dendrimer-conjugated triamcinolone acetonide attenuates nerve injury-induced spinal cord microglia activation and mechanical allodynia.
Kim H; Choi B; Lim H; Min H; Oh JH; Choi S; Cho JG; Park JS; Lee SJ
Mol Pain; 2017 Jan; 13():1744806917697006. PubMed ID: 28326946
[TBL] [Abstract][Full Text] [Related]
5. Systemic dendrimer nanotherapies for targeted suppression of choroidal inflammation and neovascularization in age-related macular degeneration.
Kambhampati SP; Bhutto IA; Wu T; Ho K; McLeod DS; Lutty GA; Kannan RM
J Control Release; 2021 Jul; 335():527-540. PubMed ID: 34058271
[TBL] [Abstract][Full Text] [Related]
6. Triamcinolone reduces neovascularization, capillary density and IGF-1 receptor phosphorylation in a model of oxygen-induced retinopathy.
Hartnett ME; Martiniuk DJ; Saito Y; Geisen P; Peterson LJ; McColm JR
Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4975-82. PubMed ID: 17065516
[TBL] [Abstract][Full Text] [Related]
7. Selective Targeting and Tissue Penetration to the Retina by a Systemically Administered Vascular Homing Peptide in Oxygen Induced Retinopathy (OIR).
Vähätupa M; Salonen N; Uusitalo-Järvinen H; Järvinen TAH
Pharmaceutics; 2021 Nov; 13(11):. PubMed ID: 34834347
[TBL] [Abstract][Full Text] [Related]
8. Myeloid cell modulation by a GLP-1 receptor agonist regulates retinal angiogenesis in ischemic retinopathy.
Zhou L; Xu Z; Oh Y; Gamuyao R; Lee G; Xie Y; Cho H; Lee S; Duh EJ
JCI Insight; 2021 Dec; 6(23):. PubMed ID: 34673570
[TBL] [Abstract][Full Text] [Related]
9. Treatment with triamcinolone acetonide prevents decreased retinal levels of decorin in a rat model of oxygen-induced retinopathy.
Park YJ; Kim YH; Choi WS; Chung IY; Yoo JM
Curr Eye Res; 2010 Jul; 35(7):657-63. PubMed ID: 20597652
[TBL] [Abstract][Full Text] [Related]
10. Systemic and Intravitreal Delivery of Dendrimers to Activated Microglia/Macrophage in Ischemia/Reperfusion Mouse Retina.
Kambhampati SP; Clunies-Ross AJ; Bhutto I; Mishra MK; Edwards M; McLeod DS; Kannan RM; Lutty G
Invest Ophthalmol Vis Sci; 2015 Jul; 56(8):4413-24. PubMed ID: 26193917
[TBL] [Abstract][Full Text] [Related]
11. Posterior sub-Tenon's capsule injection of triamcinolone acetonide prevents panretinal photocoagulation-induced visual dysfunction in patients with severe diabetic retinopathy and good vision.
Shimura M; Yasuda K; Shiono T
Ophthalmology; 2006 Mar; 113(3):381-7. PubMed ID: 16458970
[TBL] [Abstract][Full Text] [Related]
12. Effect of triamcinolone acetonide on retinal inflammation and angiogenesis induced by pericyte depletion in mouse.
Otsuka T; Masuda T; Takahashi Y; Suzuki A; Uemura A; Arakawa R; Okabe T; Naito A
J Pharmacol Sci; 2023 Jan; 151(1):28-36. PubMed ID: 36522120
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of tumor necrosis factor-alpha improves physiological angiogenesis and reduces pathological neovascularization in ischemic retinopathy.
Gardiner TA; Gibson DS; de Gooyer TE; de la Cruz VF; McDonald DM; Stitt AW
Am J Pathol; 2005 Feb; 166(2):637-44. PubMed ID: 15681845
[TBL] [Abstract][Full Text] [Related]
14. Triamcinolone suppresses retinal vascular pathology via a potent interruption of proinflammatory signal-regulated activation of VEGF during a relative hypoxia.
Kim YH; Chung IY; Choi MY; Kim YS; Lee JH; Park CH; Kang SS; Roh GS; Choi WS; Yoo JM; Cho GJ
Neurobiol Dis; 2007 Jun; 26(3):569-76. PubMed ID: 17434742
[TBL] [Abstract][Full Text] [Related]
15. Subconjunctival therapy by cubic liquid crystalline nanoparticles to deliver Triamcinolone acetonide for the management of diabetic Retinopathy: In vivo evidences.
Sharadha M; Vishal Gupta N; Rahamathulla M; Muqtader Ahmed M; Ayesha Farhana S; Osmani RAM; Veeranna B; Koteshwara KB
Int J Pharm; 2023 Nov; 646():123443. PubMed ID: 37748633
[TBL] [Abstract][Full Text] [Related]
16. Retinal vascular repair and neovascularization are not dependent on CX3CR1 signaling in a model of ischemic retinopathy.
Zhao L; Ma W; Fariss RN; Wong WT
Exp Eye Res; 2009 Jun; 88(6):1004-13. PubMed ID: 19176215
[TBL] [Abstract][Full Text] [Related]
17. Dendrimer-based targeted intravitreal therapy for sustained attenuation of neuroinflammation in retinal degeneration.
Iezzi R; Guru BR; Glybina IV; Mishra MK; Kennedy A; Kannan RM
Biomaterials; 2012 Jan; 33(3):979-88. PubMed ID: 22048009
[TBL] [Abstract][Full Text] [Related]
18. MiR-203a-3p inhibits retinal angiogenesis and alleviates proliferative diabetic retinopathy in oxygen-induced retinopathy (OIR) rat model via targeting VEGFA and HIF-1α.
Han N; Xu H; Yu N; Wu Y; Yu L
Clin Exp Pharmacol Physiol; 2020 Jan; 47(1):85-94. PubMed ID: 31408201
[TBL] [Abstract][Full Text] [Related]
19. [Pathological role of apelin in angiogenic eye disease].
Kasai A
Yakugaku Zasshi; 2011; 131(8):1201-6. PubMed ID: 21804324
[TBL] [Abstract][Full Text] [Related]
20. Microglia in retinal angiogenesis and diabetic retinopathy.
Hu A; Schmidt MHH; Heinig N
Angiogenesis; 2024 Apr; ():. PubMed ID: 38564108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
